Publication | Closed Access

In Vitro Cytotoxicity of Low-Dose-Rate Radioimmunotherapy by the Alpha-Emitting Radioimmunoconjugate Thorium-227–DOTA–Rituximab

Radiation MedicineEngineeringRadiation TherapyImmunotherapyRadionuclide TherapyMedicineImmunologyRadiopharmaceuticalsAlpha-emitting Radioimmunoconjugate Thorium-227–dota–rituximabLow-dose-rate RadioimmunotherapyVitro CytotoxicityRadiopharmaceutical TherapyRadiation EffectsOncologyRadiation OncologyAlpha Particle TherapyNuclear MedicineCancer Research